Published in Mol Gen Mikrobiol Virusol on January 01, 2006
Antibiotic resistance and single-nucleotide polymorphism cluster grouping type in a multinational sample of resistant Mycobacterium tuberculosis isolates. Antimicrob Agents Chemother (2007) 0.82
Adverse events in the treatment of multidrug-resistant tuberculosis: results from the DOTS-Plus initiative. Int J Tuberc Lung Dis (2004) 2.87
Adverse reactions among patients being treated for MDR-TB in Tomsk, Russia. Int J Tuberc Lung Dis (2007) 1.96
Treatment outcomes in an integrated civilian and prison MDR-TB treatment program in Russia. Int J Tuberc Lung Dis (2006) 1.94
Treating multidrug-resistant tuberculosis in Tomsk, Russia: developing programs that address the linkage between poverty and disease. Ann N Y Acad Sci (2007) 1.21
[Attempts to develop a vaccine against Ebola fever]. Vopr Virusol (1996) 1.00
[Design of virus-like particles, exposing HIV-1 epitopes]. Mol Biol (Mosk) (2000) 0.83
[Production of a viable variant of the M13 phage with a foreign peptide inserted into the basic coat protein]. Dokl Akad Nauk SSSR (1989) 0.80
A prototype prophylactic anti-influenza preparation in aerosol form on the basis of Abies sibirica polyprenols. J Aerosol Med (2005) 0.79
Effect of intramuscularly injected polyprenols on influenza virus infection in mice. Antivir Chem Chemother (2000) 0.78
Inserting foreign peptides into the major coat protein of bacteriophage M13. FEBS Lett (1992) 0.77
[Differentiation of the Mycobacterium tuberculosis W-Beijing family strains from the Russian Federation by the VNTR-typing]. Mol Gen Mikrobiol Virusol (2005) 0.76
[Mutagenesis, induced by phosphotriester analogs of oligonucleotides and directed to the cleavage site of double-spiral DNA]. Mol Gen Mikrobiol Virusol (1991) 0.75
[Expression of a hybrid protein between human gamma-interferon and alpha-fetoprotein in E. coli cells]. Mol Biol (Mosk) (1997) 0.75
[Site-specific mutagenesis in vivo directed by phosphoester analogs of oligonucleotides]. Dokl Akad Nauk SSSR (1989) 0.75
[Effect of tripeptide Pro-Gly-Pro on rat brain transcriptome in focal ischemia]. Mol Biol (Mosk) (2015) 0.75
[Antiviral activity of mutant interferons. A new approach to the study of structural-functional organization of interferons]. Bioorg Khim (1987) 0.75
[The use of filamentous phage M13 in protein engineering]. Mol Biol (Mosk) (1990) 0.75
Moving nonradiating kinks in nonlocal φ4 and φ4-φ6 models. Phys Rev E Stat Nonlin Soft Matter Phys (2011) 0.75
[Variants of phage M13 DNA containing a fragment of the beta-galactosidase gene--a convenient mutation system for the study of oligonucleotide-directed mutagenesis]. Bioorg Khim (1986) 0.75
[Photochemotherapy in the treatment of acute pneumonias]. Vestn Ross Akad Med Nauk (1994) 0.75
Artificial mycobacterial particles for immunization against tuberculosis. Dokl Biol Sci (2003) 0.75
[Changes in lower urinary tract function in children with hyperactive urinary bladder treated with combined therapy]. Urologiia (2007) 0.75
[Construction of the gene of hybrid hemagglutinin of influenza virus H1-H3 subtype using methods of localized mutagenesis]. Dokl Akad Nauk SSSR (1988) 0.75
[Stabilization of influenza virus with antioxidants]. Vopr Virusol (1999) 0.75
[Mechanisms of mice resistance to influenza virus A/AICHI/2/68 after preventive injection with polyprenols ]. Vopr Virusol (2001) 0.75
[Proteomic analysis of mitochondria from the Bos taurus heart. II. Identification of mitochondrial soluble proteins]. Bioorg Khim (2009) 0.75
[Molecular genetic characteristics of rifampicin-resistant Mycobacterium tuberculosis isolates in Novosibirsk]. Probl Tuberk Bolezn Legk (2003) 0.75
[Laboratory service optimization in the implementation of a complex programme for detection and treatment patients with tuberculosis]. Klin Lab Diagn (2005) 0.75
[Genetic polymorphism of clinical Mycobacterium tuberculosis strains circulating in the territory of Novosibirsk Region]. Vestn Ross Akad Med Nauk (2005) 0.75
[Chemical analysis of qualitative and quantitative composition of urinary concrements]. Klin Lab Diagn (1995) 0.75
[Study of a role of artificial mycobacterial particles in the realization of immunological processes in experimental animal tuberculosis]. Probl Tuberk Bolezn Legk (2007) 0.75
[Isolation of mutant genes for human leukocyte alpha2-interferon by a method of localized mutagenesis]. Mol Gen Mikrobiol Virusol (1985) 0.75
[Elaboration of live measles vaccine technology on human embryo lung diploid cell culture L-68]. Vestn Ross Akad Med Nauk (1998) 0.75
[Study of antituberculous activity of moxifloxacin conjugate with macrophage scavenger-receptor ligand]. Antibiot Khimioter (2006) 0.75
[Construction of peptide mimetics of an epitope of the human immunodeficiency virus (HIV-1) gp41 protein, recognized by virus-neutralizing antibodies 2F5]. Mol Biol (Mosk) (2001) 0.75
[Mutant human gamma-interferons with a changed C-terminus and their properties]. Mol Biol (Mosk) (1996) 0.75
[Experimental model and possible molecular mechanism of induced deletion mutagenesis]. Dokl Akad Nauk SSSR (1986) 0.75
[Development of the disease in marmot at the intranasal infection with the monkeypox virus]. Vopr Virusol (2015) 0.75
[Construction and expression in Escherichia coli of a gene of hybrid hemagglutinin H1-H3 of influenza virus]. Mol Biol (Mosk) (1990) 0.75
[Specific modification of DNA at E. coli RNA-polymerase binding sites]. Mol Gen Mikrobiol Virusol (1985) 0.75
[Use of recombinant species-specific proteins M. tuberculosis for the serological diagnosis of tuberculosis]. Klin Lab Diagn (2006) 0.75
[Directed reconstruction of the influenza virus hemagglutinin gene]. Mol Biol (Mosk) (1991) 0.75
[Effectiveness of substituting E. coli DNA-polymerase for DNA-polymerase A in oligonucleotide-directed mutagenesis]. Bioorg Khim (1987) 0.75
[Precise resection of the lung using neodymium YAG laser]. Probl Tuberk (1992) 0.75
[A new primer for sequencing DNA fragments cloned in M13mp vectors]. Bioorg Khim (1987) 0.75
[Mutagenesis, directed by artificial oligonucleotide analogs. I. Participation of ribonucleotide fragments in DNA replication and repair]. Mol Biol (Mosk) (1991) 0.75
[Study of the mechanism of mutagenesis directed by phosphotriester analogs of oligonucleotides. The role of repair in mutagenesis]. Mol Biol (Mosk) (1990) 0.75
[Mutagenic properties of phosphotriester analogs of oligodeoxyribonucleotides]. Mol Biol (Mosk) (1989) 0.75
Mutagenesis directed by phosphotriester analogues of oligonucleotides: a way to site-specific mutagenesis in vivo. FEBS Lett (1988) 0.75
[Introduction of statistical mutations into strictly defined areas of the genome using a modified oligonucleotide]. Mol Biol (Mosk) (1992) 0.75
[Molecular and genetic characterization of rifampicin- and/or izoniazid-resistent strains of M. tuberculosis, isolated in Novosibirsk and Tomsk regions]. Vestn Ross Akad Med Nauk (2005) 0.75
[The mutagenic activity of N4-(4-aminobutoxy)-2'-deoxycytidine-5'-triphosphate]. Mol Biol (Mosk) (1995) 0.75
[Mutagenesis directed by phosphotriester analogs of oligonucleotides: a way to site-specific mutagenesis in vivo]. Mol Gen Mikrobiol Virusol (1989) 0.75
[Enhancement of epidermal regeneration by recombinant vaccinia virus growth factor]. Vestn Ross Akad Med Nauk (1998) 0.75
[Mutagenesis directed by phosphotriester analogs of oligonucleotides]. Bioorg Khim (1986) 0.75
[Mutant human gamma-interferons with varied C-termini and their properties]. Dokl Akad Nauk (1994) 0.75
[Mutant human gamma-interferon with increased antiviral activity]. Dokl Akad Nauk (1996) 0.75
[Primary structure of the mutant genes of human leukocyte interferon alpha2]. Bioorg Khim (1988) 0.75
[Study of the effect of chicken embryo homogenate on the growth and metastasis of sarcoma of Pliss in rats]. Vopr Onkol (1996) 0.75
[Expression in Escherichia coli of the human leukocyte interferon alpha2 gene fused with N-terminal fragment of beta-galactosidase]. Mol Gen Mikrobiol Virusol (1988) 0.75
[A comparative study of the antiviral activity of chemical compounds concerning the orthopoxviruses experiments in vivo]. Vopr Virusol (2013) 0.75
[Structure-activity organization of leukocytic interferon]. Mol Biol (Mosk) (1991) 0.75
[Use of metaiodobenzylguanidine for assessing status of ends of myocardial sympathetic nerves in myocardium of patients with bronchial asthma]. Ter Arkh (2003) 0.75
[Site-localized mutagenesis directed by phosphotriester analogs of oligonucleotides]. Bioorg Khim (1986) 0.75
[Rotaviruses in younger children in Novosibirsk in 2005-2007: detection and genotyping]. Zh Mikrobiol Epidemiol Immunobiol (2008) 0.75
[Study of the mutagenic properties of oligonucleotides containing and internucleotide pyrophosphate bond using a mutation system based on phage M13]. Mol Biol (Mosk) (1992) 0.75
[Evaluation of biochips for the rifampin resistance detection of M. tuberculosis in strains isolated at the Novosibirsk and Tomsk regions]. Mol Gen Mikrobiol Virusol (2007) 0.75